PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-33.55%
Negative revenue growth while MTDR stands at 7.85%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-48.52%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-1010.00%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-1010.00%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
5.68%
Positive net income growth while MTDR is negative. John Neff might see a big relative performance advantage.
15.01%
Positive EPS growth while MTDR is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
15.01%
Positive diluted EPS growth while MTDR is negative. John Neff might view this as a strong relative advantage in controlling dilution.
11.01%
Share count expansion well above MTDR's 12.35%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
11.01%
Diluted share count expanding well above MTDR's 12.35%. Michael Burry would fear significant dilution to existing owners' stakes.
-12.29%
Dividend reduction while MTDR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-38.17%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-75.20%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-76.02%
Negative 10Y revenue/share CAGR while MTDR stands at 434.26%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-50.46%
Negative 5Y CAGR while MTDR stands at 434.26%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-0.62%
Negative 3Y CAGR while MTDR stands at 44.25%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-64.83%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-70.74%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-58.66%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-298.53%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-179.55%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
4.91%
Positive short-term CAGR while MTDR is negative. John Neff would see a clear advantage in near-term profit trajectory.
-40.28%
Negative equity/share CAGR over 10 years while MTDR stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-59.15%
Negative 5Y equity/share growth while MTDR is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
0.08%
Below 50% of MTDR's 56.15%. Michael Burry suspects a serious short-term disadvantage in building book value.
-42.09%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-77.93%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-77.97%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-20.11%
Firm’s AR is declining while MTDR shows 37.70%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
10.89%
Inventory growth well above MTDR's 17.64%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-16.61%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-26.01%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-12.14%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-6.80%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.